Musculoskeletal Outcomes After Bone Marrow Transplant

This study has been completed.
Sponsor:
Information provided by:
Sidney Kimmel Comprehensive Cancer Center
ClinicalTrials.gov Identifier:
NCT00558948
First received: November 14, 2007
Last updated: August 18, 2009
Last verified: August 2009
  Purpose

The purpose of the study is to evaluate bone mineral density and muscle strength in survivors of bone marrow transplant. Association with age, type of transplant, steroids, years since transplant, body composition, endocrinopathies, radiation, quality of life and physical activity will be explored.


Condition
Survivors of Bone Marrow Transplant
Autologous and Allogeneic

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Musculoskeletal Outcomes After Bone Marrow Transplant

Resource links provided by NLM:


Further study details as provided by Sidney Kimmel Comprehensive Cancer Center:

Enrollment: 48
Study Start Date: May 2007
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Bone marrow transplant survivors are at risk of diminished bone mineral density. Mechanisms and risks are not well understood. This study will help identify risks factors for developing this complication.

  Eligibility

Ages Eligible for Study:   8 Years to 30 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Survivors of bone marrow transplant (autologous and allogeneic) who are at least 1 year from transplant.

Criteria

Inclusion Criteria:

  • Ages 8-30 years
  • One year from transplant

Exclusion Criteria:

  • No current steroid use
  • Medical conditions that would prohibit testing
  • Neuropsychological conditions that prohibit completing questionnaires
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00558948

Locations
United States, Maryland
Johns Hopkins University, Bayview Campus
Baltimore, Maryland, United States, 21212
Sponsors and Collaborators
Sidney Kimmel Comprehensive Cancer Center
Investigators
Study Director: Kathy Ruble, PhDc, RN Johns Hopkins University, School of Nursing
  More Information

No publications provided

Responsible Party: Kathy Ruble, PhDc, RN, SKCCC
ClinicalTrials.gov Identifier: NCT00558948     History of Changes
Other Study ID Numbers: J06120, 1F31NR010038-01
Study First Received: November 14, 2007
Last Updated: August 18, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Sidney Kimmel Comprehensive Cancer Center:
Bone Marrow Transplant
Bone Mineral Density
Survivors
Muscle Strength

ClinicalTrials.gov processed this record on September 18, 2014